| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |